益佰制药：公司独立董事变动

Core Points - The company announced the resignation of independent director Chen Yisong due to personal reasons, effective immediately [1] - Following the resignation, the company plans to appoint Liang Liang as a candidate for independent director in the upcoming board meeting [1] Summary by Sections - Director Resignation - Chen Yisong has submitted his resignation from the position of independent director and various committee roles within the company [1] - Board Meeting and New Appointment - The company will hold its 14th meeting of the 8th board on November 10, 2025, to discuss the proposal for appointing Liang Liang as the new independent director [1]